Good At

He specializes in endoscopic minimally invasive and open surgery for complex and difficult hepatobiliary surgical diseases, as well as liver transplantation for end-stage liver disease.

Introduction

Tan Weifeng, male, visiting scholar at the University of Pittsburgh Medical Center, PhD, chief physician, postdoctoral supervisor. He is currently the director of the Hepatobiliary Surgery Center of Tongji Hospital Affiliated to Tongji University. Both of them graduated from the Second Military Medical University of the People's Liberation Army of China. They have served as a physician and attending physician in the Second Department of Liver and Hepatobiliary Surgery Hospital, deputy chief physician and associate professor of the First Department of Gallbladder Surgery, Shanghai Oriental Hepatobiliary Surgery Hospital, secretary and head of the Party Branch of Endoscopic Surgery, Shanghai Oriental Hepatobiliary Surgery Hospital, director and chief physician, director and chief physician of the liver surgery ward of Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. Since 2005, he has been engaged in liver transplantation for end-stage hepatobiliary diseases, such as liver transplantation for patients with decompensated cirrhosis, liver transplantation for patients with liver cirrhosis combined with liver cancer, liver transplantation for patients with liver cirrhosis combined with hilar cholangiocarcinoma, liver transplantation for patients with biliary cirrhosis, etc. Since 2013, hepatobiliary laparoscopic surgery has been carried out, achieving laparoscopic resection of massive liver cancer, laparoscopic right hepatectomy, laparoscopic extended left hepatectomy, laparoscopic radical resection of intrahepatic bile duct cancer combined with caudate lobe resection, laparoscopic radical resection of hilar bile duct cancer and lower bile duct cancer, laparoscopic choledochal cyst resection, hepatobiliary plastic and cholangiojejunostomy. A series of major surgical breakthroughs such as laparoscopic radical resection of pancreatic tumors. Since he started medicine, he has received a total of more than 4 million yuan in various funds. He also serves as an expert in government procurement review in Shanghai City. In 2011, he was selected as a new top student in the health system of Shanghai City. He specializes in the diagnosis and treatment of difficult diseases in hepatobiliary surgery, minimally invasive surgical treatment of hepatobiliary endoscopy, and liver transplantation for end-stage hepatobiliary diseases. 2015-2016 Visiting at the University of Pittsburgh Medical Center in 1999.